Skip to main content
. Author manuscript; available in PMC: 2014 Apr 9.
Published in final edited form as: Breast Cancer Res Treat. 2013 Apr 9;138(3):951–959. doi: 10.1007/s10549-013-2519-9

Table 3.

Hazard ratios (HR) and 95% CIs for any recurrence, distant metastasis and death according to peridiagnostic BMI

BMI
(kg/m2)		 N cases Any recurrence * Distant metastasis * Death (any cause) *
N
events		 Semi-adjusted
HR (95% CI)		 Fully-adjusted
HR (95% CI)		 N
events		 Semi-adjusted
HR (95% CI)		 Fully-adjusted
HR (95% CI)		 N
events		 Semi-adjusted
HR (95% CI)		 Fully-adjusted
HR (95% CI)
<25 531 109 1 1 97 1 1 117 1 1
≥25 482 127 1.44 (1.09-1.91) 1.38 (1.03-1.84) 122 1.57 (1.17-2.10) 1.49 (1.10-2.0) 136 1.22 (0.93-1.60) 1.16 (0.88-1.53)
*

Models adjusted for menopausal status and stratified by estrogen receptor status, progesterone receptor status, disease stage, and age. Semi-adjusted models exclude fasting glusose, fully-adjusted models include fasting glucose.